Summary
For Year 2026-27, Influx Healthtech reports the following shareholding: Total Promoters at 73.53%, Mutual Fund at 0%, Insurance at 0.07%, Foreign Institutional Investors at 0.16%, Domestic Institutional Investors at 5.58%, and Retail at 20.66%. This breakdown provides a quick snapshot of ownership distribution for Influx Healthtech in 2026-27.
Influx Healthtech FAQs
As of 04-2026, the promoter shareholding in Influx Healthtech stands at 73.53% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Influx Healthtech is 0.16% and 5.58% respectively.
The retail shareholding of the Influx Healthtech is 20.66%.
Changes in shareholding patterns of Influx Healthtech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Influx Healthtech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
